MTRX(MTRX)
MTRX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $952M | $998M | $995M | $1.02B |
| Low | $942M | $987M | $984M | $1.01B |
| High | $962M | $1.01B | $1.01B | $1.04B |
| EBITDA Avg | $6M | $6M | $6M | $6M |
| Low | $6M | $6M | $6M | $6M |
| High | $6M | $6M | $6M | $6M |
| EBIT Avg | $8M | $9M | $9M | $9M |
| Low | $8M | $9M | $9M | $9M |
| High | $9M | $9M | $9M | $9M |
| Net Income Avg | $20M | $23M | $21M | $23M |
| Low | $16M | $19M | $21M | $22M |
| High | $22M | $25M | $21M | $23M |
| EPS Avg | $0.69 | $0.79 | $0.76 | $0.82 |
| Low | $0.58 | $0.69 | $0.75 | $0.81 |
| High | $0.80 | $0.89 | $0.77 | $0.83 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $234M | $238M | $228M | $248M |
| Low | $225M | $228M | $219M | $239M |
| High | $243M | $247M | $237M | $258M |
| EBITDA Avg | $1M | $1M | $1M | $2M |
| Low | $1M | $1M | $1M | $1M |
| High | $1M | $2M | $1M | $2M |
| EBIT Avg | $2M | $2M | $2M | $2M |
| Low | $2M | $2M | $2M | $2M |
| High | $2M | $2M | $2M | $2M |
| Net Income Avg | $5M | $5M | $5M | $5M |
| Low | $4M | $5M | $4M | $5M |
| High | $7M | $5M | $5M | $5M |
| EPS Avg | $0.18 | $0.18 | $0.16 | $0.18 |
| Low | $0.13 | $0.18 | $0.15 | $0.17 |
| High | $0.23 | $0.19 | $0.17 | $0.19 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 |